Ikena Oncology Inc (IKNA) — Capital Reinvestment Ratio

Latest as of December 2019: 0.01x

Ikena Oncology Inc (IKNA) has a Capital Reinvestment Ratio of 0.01x as of December 2019, meaning it reinvests 0% of its operating cash flow ($47.93 Million) in capital expenditures ($316.00K). Check Ikena Oncology Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$47.93 Million
USD

Capital Expenditures

$316.00K
USD

Data as of

Dec 2019
Most recent filing

Ikena Oncology Inc Capital Reinvestment Ratio (2019–2019)

This chart tracks Ikena Oncology Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Ikena Oncology Inc (IKNA) cash conversion ratio.

Annual Capital Reinvestment Ratio for Ikena Oncology Inc (2019–2019)

Year-by-year Capital Reinvestment Ratio for Ikena Oncology Inc from 2019 to 2019. See Ikena Oncology Inc (IKNA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.01x $47.93 Million $316.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow